SUENAGA, M., ZHANG, W., MASHIMA, T., SCHIRRIPA, M., CAO, S., OKAZAKI, S., . . . LENZ, H. (2021). Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients. Cancer Genomics Proteomics.
Styl ChicagoSUENAGA, MITSUKUNI, et al. "Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients." Cancer Genomics Proteomics 2021.
Citace podle MLASUENAGA, MITSUKUNI, et al. "Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients." Cancer Genomics Proteomics 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..